My Saved Searches

Keywords

Locations

Followed Suppliers

Commodity Codes

Contract Vehicles

My Notes

Followed Opportunities

My Team

MCDC

General Info

Contact Info

Size & Minority

Certifications

Product and Services

Past Experience

Existing Contracts

External Recognition

Documents

Location Served

Free

Follow the steps to access the new features. On average, completed pages of organizations are visited 30% more often.

Complete your Page

Resume

Vaccines, Pediatric Vaccines, Polio Injectable Vaccines, Severe Acute Respiratory Syndrome (SARS) Vaccine,  Vaccine Candidate, Yellow Fever Vaccine Information, Adjuvanted Recombinant Vaccine Production, Vaccine Development, Recombinant DNA Platform, Diabetes &amp; Cardiovascular Diseases, Oncology, Immunology, Multiple Sclerosis, Rare Blood Disorders, Clinical Trials &amp; Results, Immunology &amp; Inflammation, Cancer Therapy, Molecular Oncology, Monoclonal Antibodies, Messenger RNA (mRNA), Antibody-Drug Conjugates, Antibody Therapies, Hemophilia A and B Treatment, Acquired Thrombotic Thrombocytopenic Purpura (aTTP), Neurologic Disease Therapies, Healthcare Solutions, Vaccines Development,  Solutions, Dermatology, Endocrinology, Gastroenterology,  Diseases Vaccine Development,  Coronavirus (COVID-19) - Vaccines and Therapeutics, SARS-CoV-2.

Sanofi is a healthcare company engaged in the research, development, manufacturing, and marketing of innovative  solutions.

SANOFI U.S.

Sanofi is a healthcare company engaged in the research, development, manufacturing, and marketing of innovative  solutions. It covers areas such as diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health, and the new G enzyme. Its products include prescriptions and over-the-counter drugs for thrombosis, cardiovascular disease, diabetes, central nervous system disorders, oncology and internal medicine, vaccines, and other medical products. The two young groups Sanofi and Synthélabo merged in May 1999 to create a major new pharmaceutical player. Sanofi dates back to 1973 and Synthélabo to 1970. In December 1999, Rhône-Poulenc and Hoechst Marion Roussel formalized their merger with the creation of the Franco-German group Aventis, one of the world’s largest pharmaceutical companies. In August 2004, Sanofi-Synthelabo acquired Aventis. The takeover was finalized on December 31 of that year, giving birth to Sanofi-Aventis. On May 6, 2011, Sanofi-Aventis simplified its name to Sanofi. Sanofi operates in over 100 countries throughout the world.